International consortium to develop rapid metagenomic NGS solutions that can identify known and novel respiratory pathogens, reduce time-to-diagnosis, and enhance hospital decision-making and public ...
Aktien»Nachrichten»GINKGO BIOWORKS AKTIE»Ginkgo Bioworks Partners with HaDEA in Up to €24 Million Consortium Project to Deliver Next-Generation 'Agnostic Diagnostics' for Respiratory Viruses at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results